Related Experiment Video
Updated: Jun 3, 2025
Synthesis and Characterization of Functionalized Metal-organic Frameworks
Published on: September 5, 2014
Immunoadjuvant-functionalized metal-organic frameworks: synthesis and applications in tumor immune modulation
Chen Zhao1, Weihua Song2, Jianing Wang3
1School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China. jiangzhenqi@bit.edu.cn.
Abstract:
Cancer immunotherapy, which leverages the body's immune system to recognize and attack cancer cells, has made significant progress, particularly in the treatment of metastatic tumors. However, challenges such as drug stability and off-target effects still limit its clinical success. To address these issues, metal-organic frameworks (MOFs) have emerged as promising nanocarriers in cancer immunotherapy. MOFs have unique porous structure, excellent drug loading capacity, and tunable surface modification properties. MOFs not only enhance drug delivery efficiency but also allow for precise control of drug release. They reduce off-target effects and significantly improve targeting and therapy efficacy. As research deepens, MOFs' effectiveness as drug carriers has been refined. When combined with immunoadjuvants or anticancer drugs, MOFs further stimulate the immune response. This improves the specificity of immune attacks on tumors. This review provides a comprehensive overview of the applications of MOFs in cancer immunotherapy. It focuses on synthesis, drug loading strategies, and surface modifications. It also analyzes their role in enhancing immunotherapy effectiveness. By integrating current research, we aim to provide insights for the future development of immunoadjuvant-functionalized MOFs, accelerating their clinical application for safer and more effective cancer treatments.
Insights
Metal-organic frameworks (MOFs) are advanced nanocarriers enhancing cancer immunotherapy by improving drug delivery and reducing side effects. This review explores MOF applications for more effective and targeted cancer treatments.
Area of Science:
- Biomedical Engineering
- Materials Science
- Immunology
Background:
- Cancer immunotherapy shows promise for metastatic tumors but faces challenges like drug stability and off-target effects.
- Metal-organic frameworks (MOFs) offer unique properties as nanocarriers, including porous structures and tunable surfaces.
- MOFs can improve drug delivery efficiency, control release, and reduce adverse effects in cancer therapy.
Purpose of the Study:
- To provide a comprehensive overview of MOF applications in cancer immunotherapy.
- To focus on MOF synthesis, drug loading, and surface modification strategies.
- To analyze MOFs' role in enhancing immunotherapy effectiveness and guiding future development.
Main Methods:
- Review of current research on MOFs in cancer immunotherapy.
- Analysis of MOF synthesis and functionalization techniques.
- Evaluation of MOF-based drug delivery systems for enhanced immune response.
Main Results:
- MOFs enhance drug delivery efficiency and enable precise control over drug release.
- MOFs reduce off-target effects, improving targeting and therapeutic efficacy.
- Combining MOFs with immunoadjuvants or anticancer drugs stimulates immune response and tumor specificity.
Conclusions:
- MOFs are effective nanocarriers for cancer immunotherapy, improving drug stability and delivery.
- Functionalized MOFs can significantly enhance immune response against tumors.
- Further development of immunoadjuvant-functionalized MOFs can accelerate clinical applications for safer cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
02:17The Tumor Microenvironment